Based in Oxford, England, Oxford Sciences Innovation (OSI) specializes in investments in spin-outs from Oxford University’s technology, mathematical, physical, life sciences and medical sciences departments. OSI has raised £580 million ($706 million), with first-round investors including Google Ventures and the Wellcome Trust and the second round led by Asian investors. Since its foundation in April 2015, the organization has provided financial support to 22 companies, including biotech spinouts Evox, Vaccitech and DJS Antibodies.
Oxford Investment Consultants LLP is an investment advisor that covers life sciences, healthcare and technology in the United Kingdom. The firm prefers to make investments in the University of Oxford spin out companies. Oxford Investments Consultants LLP is based in the United Kingdom.
TheraNova is an experienced medical device developer with a track record of creating innovative and practical solutions to large markets with unmet needs. TheraNova pursues a rapid, highly capital-efficient process incorporating all the needed elements of medical device development in a shared services model. Since its inception in 2005, TheraNova has been able to generate clinical data within a year of funding and with less than $1M in financing.
